Literature DB >> 27546878

The neurocircuitry involved in oxytocin modulation of methamphetamine addiction.

Sarah J Baracz1, Jennifer L Cornish2.   

Abstract

The role of oxytocin in attenuating the abuse of licit and illicit drugs, including the psychostimulant methamphetamine, has been examined with increased ferocity in recent years. This is largely driven by the potential application of oxytocin as a pharmacotherapy. However, the neural mechanisms by which oxytocin modulates methamphetamine abuse are not well understood. Recent research identified an important role for the accumbens core and subthalamic nucleus in this process, which likely involves an interaction with dopamine, glutamate, GABA, and vasopressin. In addition to providing an overview of methamphetamine, the endogenous oxytocin system, and the effects of exogenous oxytocin on drug abuse, we propose a neural circuit through which exogenous oxytocin modulates methamphetamine abuse, focusing on its interaction with neurochemicals within the accumbens core and subthalamic nucleus. A growing understanding of exogenous oxytocin effects at a neurochemical and neurobiological level will assist in its evaluation as a pharmacotherapy for drug addiction. Crown Copyright Â
© 2016. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Addiction; Methamphetamine; Nucleus accumbens core; Oxytocin; Subthalamic nucleus

Mesh:

Substances:

Year:  2016        PMID: 27546878     DOI: 10.1016/j.yfrne.2016.08.001

Source DB:  PubMed          Journal:  Front Neuroendocrinol        ISSN: 0091-3022            Impact factor:   8.606


  18 in total

1.  Antagonism of mGlu2/3 receptors in the nucleus accumbens prevents oxytocin from reducing cued methamphetamine seeking in male and female rats.

Authors:  Aurelien Bernheim; Kah-Chung Leong; Carole Berini; Carmela M Reichel
Journal:  Pharmacol Biochem Behav       Date:  2017-09-01       Impact factor: 3.533

2.  Peer-induced cocaine seeking in rats: Comparison to nonsocial stimuli and role of paraventricular hypothalamic oxytocin neurons.

Authors:  Lindsey R Hammerslag; Bree A Humburg; Samantha G Malone; Joshua S Beckmann; Kathryn E Saatman; Valery Grinevich; Michael T Bardo
Journal:  Addict Biol       Date:  2022-09       Impact factor: 4.093

3.  Effect of social housing and oxytocin on the motivation to self-administer methamphetamine in female rats.

Authors:  Christel Westenbroek; Adam N Perry; Lakshmikripa Jagannathan; Jill B Becker
Journal:  Physiol Behav       Date:  2017-10-18

4.  Oxytocin attenuates phencyclidine hyperactivity and increases social interaction and nucleus accumben dopamine release in rats.

Authors:  Shivali Kohli; Madeleine V King; Stuart Williams; Adele Edwards; Theresa M Ballard; Lucinda J Steward; Daniella Alberati; Kevin C F Fone
Journal:  Neuropsychopharmacology       Date:  2018-08-07       Impact factor: 7.853

5.  The vagus nerve mediates the suppressing effects of peripherally administered oxytocin on methamphetamine self-administration and seeking in rats.

Authors:  Nicholas A Everett; Anita J Turner; Priscila A Costa; Sarah J Baracz; Jennifer L Cornish
Journal:  Neuropsychopharmacology       Date:  2020-05-25       Impact factor: 7.853

Review 6.  Alcohol and oxytocin: Scrutinizing the relationship.

Authors:  Andrey E Ryabinin; Hannah D Fulenwider
Journal:  Neurosci Biobehav Rev       Date:  2021-06-05       Impact factor: 9.052

Review 7.  Effect of early life social adversity on drug abuse vulnerability: Focus on corticotropin-releasing factor and oxytocin.

Authors:  Michael T Bardo; Lindsey R Hammerslag; Samantha G Malone
Journal:  Neuropharmacology       Date:  2021-04-13       Impact factor: 5.273

8.  Deletion of VGLUT2 in midbrain dopamine neurons attenuates dopamine and glutamate responses to methamphetamine in mice.

Authors:  Hui Shen; Kai Chen; Rosa Anna M Marino; Ross A McDevitt; Zheng-Xiong Xi
Journal:  Pharmacol Biochem Behav       Date:  2021-01-12       Impact factor: 3.697

9.  Compulsive methamphetamine taking in the presence of punishment is associated with increased oxytocin expression in the nucleus accumbens of rats.

Authors:  Irina N Krasnova; Maria Carla Gerra; Donna Walther; Subramaniam Jayanthi; Bruce Ladenheim; Michael T McCoy; Christie Brannock; Jean Lud Cadet
Journal:  Sci Rep       Date:  2017-08-21       Impact factor: 4.379

10.  Oxytocin-enhanced group therapy for methamphetamine use disorder: Randomized controlled trial.

Authors:  Christopher S Stauffer; Jenna M Moschetto; Scott McKernan; Nathan Meinzer; Chavy Chiang; Rachel Rapier; Elaine Hsiang; Jerika Norona; Brian Borsari; Joshua D Woolley
Journal:  J Subst Abuse Treat       Date:  2020-06-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.